Return
Immune profiling for improving responsiveness to ipilimumab plus nivolumab checkpoint blockade treatment in patients with metastatic melanoma
DOI:10.1158/1538-7445.AM2024-6397.png)
Abstract
En
Journal
IF:
16.6
Papers:
10.9W
Citations:
11.9W
Organization
No organization information available

